Attention deficit hyperactivity disorder Trials in Jacksonville, United States
Conditions / Attention deficit hyperactivity disorder / Jacksonville, United States
Attention deficit hyperactivity disorder has been the subject of sustained clinical investigation across multiple research sites.
33 total trials for this combination
Showing top 10 of 33 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01552902 | Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder | COMPLETED | PHASE4 |
| NCT01081145 | Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) | COMPLETED | PHASE3 |
| NCT02428088 | Dasotraline Pediatric ADHD Study | COMPLETED | PHASE2/PHASE3 |
| NCT04085172 | A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) | COMPLETED | PHASE4 |
| NCT04278404 | Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | RECRUITING | — |
| NCT01552915 | Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder | COMPLETED | PHASE4 |
| NCT01074294 | Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder | COMPLETED | PHASE2 |
| NCT05286762 | Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 | COMPLETED | PHASE3 |
| NCT03597503 | Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment | TERMINATED | PHASE3 |
| NCT05279313 | A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. | ACTIVE_NOT_RECRUITING | PHASE3 |